Cover Story

Xbp1s, a transcriptional factor that is activated in response to endoplasmic reticulum (ER) stress, is elevated in subcutaneous fat tissue from obese human subjects. This suggests that Xbp1s induction is a possible link between ER stress and obesity.

Under fasting conditions, when there are high levels of lipolysis, pyrimidine biosynthesis in adipocytes is elevated. As a result, plasma uridine concentrations double. Even though only moderate in terms of the magnitude of the change, the doubling of uridine concentrations has major implications for temperature regulation and energy expenditure.

Deng et al. find that although the expression of Xbp1s in adipocytes is induced by a number of lipolytic stimuli, lipolysis per se is not dependent on Xbp1s. Conversely, adipocyte overexpression of Xbp1s leads to profound loss of fat mass, and this loss is associated with elevation of uridine in adipose tissue and blood circulation. The authors demonstrate that Xbp1s triggered fat mass loss relies on pyrimidine biosynthesis. Also, their data suggest a direct regulatory role of ER stress in pyrimidine metabolism. Based on these observations, they propose that the stimulation of the adipocyte uridine synthesis pathway is a potential therapeutic target area for the treatment of obesity.

Full Text
The 60 Second Metabolist
In this section authors briefly report on their work recently published in Molecular Metabolism.

Watch the most recent interview by clicking the video still. The link "referring article" directs you to this author's publication.



Brandon Panaro
Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada
Referring article

Other Scientists...
Issue Alert
If you want to be alerted via email when new content that matches your interests is available, please login or register at www.sciencedirect.com/journal/molecular-metabolism
Conferences & Events
February
10 − 14
2019
Obesity and Adipose Tissue Biology
Banff, Canada
February
10 − 14
2019
Functional Neurocircuitry of Feeding and Feeding Disorders
Banff, Canada
February
24 − 28
2019
Tumor Metabolism
Keystone, USA
March
3 − 7
2019
Diabetes: Innovations, Out­comes, Personalized Therapies
Whistler, Canada
March
10 − 14
2019
Microbiome: Mechanisms and Consequences
Montreal, Canada
March
15 − 19
2019
Cancer Metastasis
Florence, Italy
Media Coverage
Supported by